Boston Scientific believes, at least for public view, the era of Jim Tobin on the day he ends his decade as CEO was highly successful, while critics note the firm’s current market value. The official Boston Scientific take is that Tobin led it to become a more diversified business with a full product pipeline. But that view has its questioners, who note Boston Scientific shares today are worth only half of what they were when Tobin took over in March, 1999. (Click here for more)
“Tally Up The Decade” – Boston Globe (7/10/09)
Get the week's top medical device news sent directly to you. Sign up for the FREE once-a-week email newsletter from Top Device Companies.com
